Economic Liberties Applauds Minnesota Legislature for Banning Noncompete Agreements
May 17, 2023 — The American Economic Liberties Project released the following statement following the Minnesota House and Senate passing SF3035 yesterday, which included a provision rendering noncompete agreements void and unenforceable.
In Blocking Amgen-Horizon, FTC Stands Up to Big Pharma Abuse and Defends Patients
May 16, 2023 — In response to news that the Federal Trade Commission is blocking Amgen’s $28 billion acquisition of Horizon Therapeutics, the American Economic Liberties Project released the following statement.
Big Pharma Cheated Americans Out of More $40 Billion, New Economic Liberties and I-MAK Report Finds
May 16, 2023 — The American Economic Liberties Project and I-MAK today released “The Costs of Pharma Cheating,” a blockbuster report that reveals rampant antitrust violations by Big Pharma corporations are costing American patients and government health programs an additional $40 billion on branded pharmaceuticals in 2019.
Solicitor General Defends CFPB Against Rogue Courts and Payday Lenders
May 9, 2023 — In response to a brief filed by the United States Solicitor General in support of the Consumer Financial Protection Bureau in CFPB v CFSA, a case challenging the constitutionality of the CFPB’s funding structure, the American Economic Liberties Project released the following statement.
Economic Liberties Applauds Minnesota House Vote on Hospital Merger Bill
May 8, 2023 — The American Economic Liberties Project released the following statement following the passage of HF 402 in the Minnesota House, which would give state enforcers new powers to block hospital mergers and create a new notification system for mergers in health care markets.